Rotella Capital Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Rotella Capital Management’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-5	Closed	-$16K	–	627
2014 Q4	$16K	Sell	5 -3	-38%	-$10.6K	0.01%	353
2014 Q3	$29K	Buy	8 +1	+14%	+$3.89K	0.03%	279
2014 Q2	$28K	Sell	7 -13	-65%	-$48.9K	0.02%	343
2014 Q1	$80K	Buy	+20	New	+$89.3K	0.1%	125

Other funds holding FRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

SGAM

Smith Group Asset Management Dallas, Texas $2.46B AUM 57.16% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Rotella Capital Management's FRTX Position: Q1 2015 in Review

Rotella Capital Management sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q1 2015, closing a stake of 5 shares — an estimated $16K sold.

Rotella Capital Management first reported a position in FRTX in Q1 2014 and held it in 4 quarters. The position peaked at $80K in Q1 2014. 60 funds tracked by Wall St. Rank hold FRTX as of Q1 2015.

Rotella Capital Management reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q1 2015 after selling out during the quarter.
Rotella Capital Management sold 5 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q1 2015, an estimated $16K.
Rotella Capital Management first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q1 2014 and held it in 4 quarters.
Rotella Capital Management's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $80K in Q1 2014.
60 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q1 2015.

Based on Rotella Capital Management's 13F filing for Q1 2015, filed 4 May 2015.